Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients
✍ Scribed by M. A. Moulin; J. P. Davy; D. Debruyne; J. C. Andersson; M. C. Bigot; R. Camsonne; E. Poilpré
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 491 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Seven chronic schizophrenic patients, stable for over 12 months on maintenance fluphenazine decanoate, were administered 40 g of alcohol orally soon after their regular injection. Blood samples for estimation of serum neuroleptic and prolactin levels were collected at various intervals over a 12 h p
Serum and cerebrospinal fluid (CSF) concentrations of fluphenazine (FPZ) were measured during nine weeks of FPZ medication in 28 patients with acute symptoms of schizophrenia. A significant correlation was found between the serum and CSF FPZ values (r = 0.70, p < 0-001) throughout the entire study.